927 related articles for article (PubMed ID: 33055262)
21. Genomic insights into multidrug-resistance, mating and virulence in Candida auris and related emerging species.
Muñoz JF; Gade L; Chow NA; Loparev VN; Juieng P; Berkow EL; Farrer RA; Litvintseva AP; Cuomo CA
Nat Commun; 2018 Dec; 9(1):5346. PubMed ID: 30559369
[TBL] [Abstract][Full Text] [Related]
22. A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009-17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance.
Chowdhary A; Prakash A; Sharma C; Kordalewska M; Kumar A; Sarma S; Tarai B; Singh A; Upadhyaya G; Upadhyay S; Yadav P; Singh PK; Khillan V; Sachdeva N; Perlin DS; Meis JF
J Antimicrob Chemother; 2018 Apr; 73(4):891-899. PubMed ID: 29325167
[TBL] [Abstract][Full Text] [Related]
23. Caspofungin-resistance in Candida auris is cell wall-dependent phenotype and potential prevention by zinc oxide nanoparticles.
Fayed B; Jayakumar MN; Soliman SSM
Med Mycol; 2021 Dec; 59(12):1243-1256. PubMed ID: 34612496
[TBL] [Abstract][Full Text] [Related]
24. Activity of anti-CR3-RP polyclonal antibody against biofilms formed by Candida auris, a multidrug-resistant emerging fungal pathogen.
Dekkerová J; Lopez-Ribot JL; Bujdáková H
Eur J Clin Microbiol Infect Dis; 2019 Jan; 38(1):101-108. PubMed ID: 30327897
[TBL] [Abstract][Full Text] [Related]
25. Candida auris: A systematic review and meta-analysis of current updates on an emerging multidrug-resistant pathogen.
Osei Sekyere J
Microbiologyopen; 2018 Aug; 7(4):e00578. PubMed ID: 29345117
[TBL] [Abstract][Full Text] [Related]
26. Candida auris-the growing menace to global health.
Lone SA; Ahmad A
Mycoses; 2019 Aug; 62(8):620-637. PubMed ID: 30773703
[TBL] [Abstract][Full Text] [Related]
27. First report of sporadic cases of Candida auris in Colombia.
Parra-Giraldo CM; Valderrama SL; Cortes-Fraile G; Garzón JR; Ariza BE; Morio F; Linares-Linares MY; Ceballos-Garzón A; de la Hoz A; Hernandez C; Alvarez-Moreno C; Le Pape P
Int J Infect Dis; 2018 Apr; 69():63-67. PubMed ID: 29421668
[TBL] [Abstract][Full Text] [Related]
28. Draft genome of a commonly misdiagnosed multidrug resistant pathogen Candida auris.
Chatterjee S; Alampalli SV; Nageshan RK; Chettiar ST; Joshi S; Tatu US
BMC Genomics; 2015 Sep; 16(1):686. PubMed ID: 26346253
[TBL] [Abstract][Full Text] [Related]
29. Candida auris in various hospitals across Kuwait and their susceptibility and molecular basis of resistance to antifungal drugs.
Ahmad S; Khan Z; Al-Sweih N; Alfouzan W; Joseph L
Mycoses; 2020 Jan; 63(1):104-112. PubMed ID: 31618799
[TBL] [Abstract][Full Text] [Related]
30. Increasing prevalence, molecular characterization and antifungal drug susceptibility of serial Candida auris isolates in Kuwait.
Khan Z; Ahmad S; Al-Sweih N; Joseph L; Alfouzan W; Asadzadeh M
PLoS One; 2018; 13(4):e0195743. PubMed ID: 29630658
[TBL] [Abstract][Full Text] [Related]
31. Screening a Repurposing Library for Inhibitors of Multidrug-Resistant Candida auris Identifies Ebselen as a Repositionable Candidate for Antifungal Drug Development.
Wall G; Chaturvedi AK; Wormley FL; Wiederhold NP; Patterson HP; Patterson TF; Lopez-Ribot JL
Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30104269
[TBL] [Abstract][Full Text] [Related]
32. Sphingolipidomics of drug resistant Candida auris clinical isolates reveal distinct sphingolipid species signatures.
Kumar M; Singh A; Kumari S; Kumar P; Wasi M; Mondal AK; Rudramurthy SM; Chakrabarti A; Gaur NA; Gow NAR; Prasad R
Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Jan; 1866(1):158815. PubMed ID: 32942047
[TBL] [Abstract][Full Text] [Related]
33. Candida auris: Epidemiology, biology, antifungal resistance, and virulence.
Du H; Bing J; Hu T; Ennis CL; Nobile CJ; Huang G
PLoS Pathog; 2020 Oct; 16(10):e1008921. PubMed ID: 33091071
[TBL] [Abstract][Full Text] [Related]
34. Genome-wide analysis of in vivo-evolved Candida auris reveals multidrug-resistance mechanisms.
Chen XF; Zhang H; Liu LL; Guo LN; Liu WJ; Liu YL; Li DD; Zhao Y; Zhu RY; Li Y; Dai RC; Yu SY; Li J; Wang T; Dou HT; Xu YC
Mycopathologia; 2024 Apr; 189(3):35. PubMed ID: 38637433
[TBL] [Abstract][Full Text] [Related]
35. Activities of nine antifungal agents against Candida auris biofilms.
Chatzimoschou A; Giampani A; Meis JF; Roilides E
Mycoses; 2021 Apr; 64(4):381-384. PubMed ID: 33270284
[TBL] [Abstract][Full Text] [Related]
36. Filamentous growth is a general feature of Candida auris clinical isolates.
Fan S; Yue H; Zheng Q; Bing J; Tian S; Chen J; Ennis CL; Nobile CJ; Huang G; Du H
Med Mycol; 2021 Jul; 59(7):734-740. PubMed ID: 33485272
[TBL] [Abstract][Full Text] [Related]
37. Genomic Diversity across Candida auris Clinical Isolates Shapes Rapid Development of Antifungal Resistance
Burrack LS; Todd RT; Soisangwan N; Wiederhold NP; Selmecki A
mBio; 2022 Aug; 13(4):e0084222. PubMed ID: 35862787
[TBL] [Abstract][Full Text] [Related]
38. Overestimation of Amphotericin B Resistance in Candida auris with Sensititre YeastOne Antifungal Susceptibility Testing: a Need for Adjustment for Correct Interpretation.
Siopi M; Peroukidou I; Beredaki MI; Spruijtenburg B; de Groot T; Meis JF; Vrioni G; Tsakris A; Pournaras S; Meletiadis J
Microbiol Spectr; 2023 Jun; 11(3):e0443122. PubMed ID: 37036351
[TBL] [Abstract][Full Text] [Related]
39. How the Pathogenic Fungus Alternaria alternata Copes with Stress via the Response Regulators SSK1 and SHO1.
Yu PL; Chen LH; Chung KR
PLoS One; 2016; 11(2):e0149153. PubMed ID: 26863027
[TBL] [Abstract][Full Text] [Related]
40. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
